30,000-40,000 people die from liver disease each year, according to the American Liver Foundation. For people who experience acute liver failure, the only proven treatment has been liver transplantation.
Researchers at the Mayo Clinic have developed and are testing an alternative to liver transplantation that can support healing and regeneration of the injured liver, and improve outcomes and reduce mortality rates for patients with acute liver failure --without requiring a transplant.Read more about the Spheroid Reservoir Bioartificial Liver and research at the Mayo Clinic
New study evaluates efficacy of PET imaging to manage chronic liver diseases
EASL governing board announces new Vice-Secretary
A web-based program is as effective as group counseling for patients with non-alcoholic fatty liver disease